Fiction has to make sense. Imagine the CEO of a major US corp so addled and full-****** that he's going into a full NMDAR-fit in the Oval. Fuck, I love it so.
BYD super mega factory. TSLA is no match for BYD. For centuries, China has a very solid manufacturing track record. So MAWA
I'll give ya credit dude... that is one bold call. Anyone else I would just roll my eyes, but you... well like I said, that is one bold call. Personally I don't think you're right, but credit where credit is due for going out on a limb like that. At least the $200 part.
If you read all the news flow it seems Tesla should be cratering but for some reason it doesn't happen. Shorting TSLA is like trying to short PLTR or CRWV. I did note a bad day today for HIMS so maybe there is a crack forming in the FOMO meme stock gang.
Yeah I heard that yesterday on Bloomberg. So like 40+% teens taking GLP-1s. Isn't it safer to just go out and play rather than take these untested drugs? No one knows the long term impact of these drugs. I hope it doesn't turn out to be another fenfen disaster. Ritalin comes mind as well.
how does that affect people not fully developed yet? would be interesting to know the demographic of those teens
“… Wegovy prescriptions for U.S. teens rose 50% last year, reaching 14.8 per 100,000. Concerns about long-term safety and insurance coverage limit broader adoption among adolescents. Experts urge balanced approach, combining lifestyle changes with medication for effective obesity management. LOS ANGELES — American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows. The average rate of teens beginning treatment with the highly effective Novo Nordisk drug grew 50% last year to 14.8 prescriptions per 100,000 adolescents, according to an analysis by health data firm Truveta. That's up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children aged 12 and older. The average rate climbed further during the first three months of this year, reaching 17.3 new prescriptions per 100,000. That still represents a minute fraction of the estimated 23,000 out of every 100,000 teens in the country who are living with obesity, and is far slower than the uptake among U.S. adults. "It's promising that more young people are using these medications, but it's still a very small percentage of patients with severe obesity that are getting access to them," said Dr. Cate Varney, director of obesity medicine at the University of Virginia Health system. "When lifestyle changes alone are insufficient, we need these additional tools." https://www.ksl.com/article/51323975/weight-loss-drug-wegovy-use-up-50-among-us-teens “ Wegovy use among US teens up 50% as obesity crisis worsens By Chad Terhune and Robin Respaut June 3, 20258:06 AM PDTUpdated a day ago https://www.reuters.com/business/he...s/wegovy-use-up-50-among-us-teens-2025-06-03/